Pliant Therapeutics, Inc.
PLRX
$1.48
$0.010.68%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.35% | -29.88% | -28.38% | -28.60% | -30.83% |
| Total Depreciation and Amortization | 15.43% | 16.32% | 11.37% | 4.51% | 0.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.07% | 32.20% | 32.07% | 51.91% | 84.91% |
| Change in Net Operating Assets | 626.54% | 402.88% | -66.25% | 553.11% | -70.33% |
| Cash from Operations | -33.64% | -8.53% | -30.66% | -11.44% | -22.96% |
| Capital Expenditure | -317.81% | -260.62% | -78.01% | -75.92% | 47.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 214.35% | 199.23% | 140.51% | 133.57% | 15.06% |
| Cash from Investing | 210.49% | 195.84% | 139.51% | 132.75% | 15.44% |
| Total Debt Issued | -- | -- | -- | 99.09% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.83% | -98.79% | -99.27% | -99.34% | 26.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 97.85% | 92.91% | 76.03% | -19.80% |
| Cash from Financing | -91.58% | -91.53% | -95.23% | -95.43% | 20.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -74.37% | 79.31% | -9.91% | -81.06% | 272.58% |